Prognostic Impact of Renal Function on 5‐Year Outcomes After Fractional Flow Reserve‐Guided Deferral of Revascularization

Ryosuke Itakura(Japanese Red Cross Society Kyoto Daini Hospital), Shinjo Sonoda(University of Occupational and Environmental Health Japan), Nobuhiro Suematsu(Saiseikai Fukuoka General Hospital), Akiko Matsuo(Japanese Red Cross Society Kyoto Daini Hospital), Tairo Kurita(Mie University), Tatsuya Saigusa(Shinshu University), Kenji Yaginuma(Juntendo University Urayasu Hospital), Jun Kikuchi(Keio University), Yuetsu Kikuta(Imperial College London), Kenichi Tsujita(Kumamoto University), Fumitoshi Toyota(Fukuoka Hospital), Tatsuki Doijiri(Seiwa Hospital), Hidenobu Terai(Kanazawa Hospital), Tomohiro Shinozaki(Department of Health), Shoichi Kuramitsu(Kokura Memorial Hospital), Nobuhiro Tanaka(Tokyo Medical University Hachioji Medical Center), Tomohiro Sakamoto(Saiseikai Kumamoto Hospital), Yoshiaki Kawase(Gifu Heart Center), Taku Asano(Amsterdam UMC Location University of Amsterdam), Takuya Mizukami(Onze Lieve Vrouwziekenhuis Hospital), Ken Harada(Ibaraki University), Takayuki Ishihara(Kansai Rosai Hospital), Manabu Ogita(Juntendo University Shizuoka Hospital), Yasutsugu Shiono(Imperial College London), Kazunori Horie(Sendai Kousei Hospital), Hitoshi Matsuo, Hiroyoshi Yokoi(Kurume University), Hiroaki Takashima(Aichi Medical University), Katsuhiko Masamura(Nakamura Memorial Hospital)
Journal of the American Heart Association
October 7, 2023
10.1161/jaha.123.030886
Cited by 4

Related Papers

Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI
|JAMA|2019|848
Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial
|The Lancet|2018|793
JCS 2018 Guideline on Diagnosis and Treatment of Acute Coronary Syndrome
|Circulation Journal|2019|582
Impact of Dual Lipid-Lowering Strategy With Ezetimibe and Atorvastatin on Coronary Plaque Regression in Patients With Percutaneous Coronary Intervention
|Journal of the American College of Cardiology|2015|453
Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy
|New England Journal of Medicine|2024|410